Modern will develop additional dose of vaccine for newly discovered "omicron" strain of coronavirus
Moderna has said it intends to develop an enhanced dose of the antiviral vaccine specifically targeting a new strain of the virus, the omicron, which has been discovered in South Africa and described by the World Health Organization as "worrying".
"Modern will rapidly develop a vaccine-specific booster vaccine candidate." is stated in the announcement of the American company.
The World Health Organization (WHO) Advisory Panel yesterday classified the new strain of coronavirus, discovered in South Africa, as a "worrying and highly contagious virus" and called it omicron.
In the same category is the delta strain of the virus that has become dominant in the world.
A number of countries around the world, including the United States, Canada, the EU and others, yesterday expressly imposed travel restrictions on countries in South Africa due to the new strain of the virus.